Clinical Trial Update: Assessment of the Efficacy and Safety of a DYnaMic Peripheral DegradatiON Myopia Disorder Control in Myopic Children ״DYMOND Study״ [Phase 2]

View source ↗

Summary

Phase 2 DYMOND trial from NovaSight is assessing efficacy and safety of a dynamic peripheral degradation therapy for myopia in children and is currently recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myopia

Drugs mentioned

• DYMOND

Snippet

Sponsor: NovaSight | Conditions: Myopia | Phase 2 | Status: RECRUITING